Abstract
Background: Nanotechnology and nanobiotechnology have emerged as novel technologies for the production and application of nanoscale materials in different pharmaceutical, medical, and biological fields. Besides, there are a bunch of recently published patents in this field. Although Carbon Nanotubes (CNTs) have various advantages and can be applied for a wide variety of purposes, their toxicity on humans is a matter of concern.
Objective: This study aimed to evaluate six different types of CNTs, including pristine, carboxylated, and hydroxylated single-walled CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) on three human cell lines.
Methods: MTT assay was employed to assess the cytotoxicity of six types of CNTs, including pristine, carboxylated, and hydroxylated forms of SWCNTs and MWCNTs on three different human cell lines.
Results: The findings of the MTT assay showed that the six different types of CNTs (100- 600 μg/mL) exhibited different levels of cytotoxicity on the three human cell lines. The observed trend presented dose-dependent cytotoxicity on the three studied cell lines, including pulmonary, skin, and gastrointestinal cell lines. SWCNT-COOH and MWCNTs accounted for the lowest cell viability in the three human cell lines.
Conclusion: In conclusion, researchers and industrial workers are recommended to be cautious while working with different types of CNT because all their toxicity dimensions have not been determined yet.
Keywords: Carbon nanotube, dose-dependent response, human cell line, toxicity, MTT assay, nanobiotechnology.
Graphical Abstract
[http://dx.doi.org/10.1021/nn900002m] [PMID: 19206243]
[http://dx.doi.org/10.1517/17460441.2012.719869] [PMID: 22950742]
[http://dx.doi.org/10.1126/science.1222453] [PMID: 23372006]
[http://dx.doi.org/10.1016/j.addr.2006.09.015] [PMID: 17113677]
[http://dx.doi.org/10.2174/157341311795542444]
[http://dx.doi.org/10.1517/17425247.2015.1004309] [PMID: 25613837]
[http://dx.doi.org/10.1016/j.fsi.2017.10.012] [PMID: 29017940]
[http://dx.doi.org/10.1016/j.fsi.2019.12.072] [PMID: 31883470]
[http://dx.doi.org/10.1002/jccs.201900417]
[http://dx.doi.org/10.1016/j.biopha.2018.05.066] [PMID: 29800914]
[http://dx.doi.org/10.1016/j.nano.2013.06.001] [PMID: 23770067]
[http://dx.doi.org/10.1016/j.jhazmat.2020.122757] [PMID: 32335377]
[http://dx.doi.org/10.1016/j.jchromb.2017.02.025] [PMID: 28419925]
[http://dx.doi.org/10.1016/j.addr.2013.10.003] [PMID: 24184373]
[http://dx.doi.org/10.1016/j.carbon.2018.02.039]
[http://dx.doi.org/10.1155/2013/578290]
[http://dx.doi.org/10.1016/j.pneurobio.2008.09.009] [PMID: 18926873]
[http://dx.doi.org/10.1016/j.biomaterials.2013.03.093] [PMID: 23623425]
[http://dx.doi.org/10.3109/15376516.2012.754534] [PMID: 23193995]
[http://dx.doi.org/10.1155/2020/6623830] [PMID: 33490247]
[PMID: 29552046]
[http://dx.doi.org/10.1093/toxsci/kfg243] [PMID: 14514958]
[http://dx.doi.org/10.4103/2277-9175.125729] [PMID: 24627848]
[http://dx.doi.org/10.1021/mp2001439] [PMID: 21688794]
[http://dx.doi.org/10.1021/nn900416z] [PMID: 19459622]
[http://dx.doi.org/10.1021/nn100069k] [PMID: 20380453]
[http://dx.doi.org/10.1016/j.toxlet.2005.06.020] [PMID: 16125885]
[http://dx.doi.org/10.1002/adma.200602667]
[http://dx.doi.org/10.1021/nn800532m] [PMID: 19206261]
[http://dx.doi.org/10.1016/j.scitotenv.2010.01.035] [PMID: 20167353]
[http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v29.i1.20] [PMID: 22356722]
[http://dx.doi.org/10.1016/j.jhazmat.2020.124107] [PMID: 33035908]
[http://dx.doi.org/10.3109/10408444.2010.506638] [PMID: 20860524]
[http://dx.doi.org/10.1016/j.addr.2013.07.019] [PMID: 23928473]